Biogen
BIIB
BIIB
1,140 hedge funds and large institutions have $52.2B invested in Biogen in 2018 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 374 increasing their positions, 452 reducing their positions, and 122 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $62.8B → $52.2B (-$10.5B)
17% less repeat investments, than reductions
Existing positions increased: 374 | Existing positions reduced: 452
26% less call options, than puts
Call options by funds: $992M | Put options by funds: $1.34B
Holders
1,140
Holding in Top 10
29
Calls
$992M
Puts
$1.34B
Top Buyers
| 1 | +$464M | |
| 2 | +$127M | |
| 3 | +$107M | |
| 4 |
Parnassus Investments
San Francisco,
California
|
+$88.8M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$59.3M |
Top Sellers
| 1 | -$196M | |
| 2 | -$177M | |
| 3 | -$150M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$145M |
| 5 |
Goldman Sachs
New York
|
-$139M |